Algeria: Nearly DZD 180 Billion Devoted to 2015-2019 National Anti-Cancer Plan
May 24, 2015 | Algerie Presse Service (Algiers)
Algiers — The overall cost of the 2015-2019 anti-cancer national plan has been estimated at nearly DZD 180 billion, according to a report on the plan presented Sunday at the Council of Ministers by the Minister of Health, Population and Hospital reform. "The total cost of the 2015-2019 national anti-cancer plan ...
read more
Regeneron (REGN), Sanofi (SNY) Announce Sarilumab Met co-Primary Endpoints in Phase 3
May 21, 2015 | Regeneron Pharmaceuticals, Inc.
Regeneron (NASDAQ: REGN) and Sanofi (NYSE: SNY) announced that a Phase 3 study of sarilumab, an investigational, fully human IL-6 receptor antibody, met its co-primary efficacy endpoints of a greater improvement in signs and symptoms of rheumatoid arthritis (RA) at 24 weeks and physical function at 12 weeks, compared to placebo ...
read more
Retina Implant's Global Study of the Alpha IMS Microchip Published in Vision Research
May 20, 2015 | Retina Implant AG
REUTLINGEN, Germany, May 20, 2015 /PRNewswire/ -- Retina Implant AG, the leading developer of subretinal implants for patients blinded by retinitis pigmentosa (RP), today announced the publication of data from the Company's global clinical trial involving seven sites across five countries. The study, published in the May 2015 edition ...
read more
Poseidon CRO celebrating International Clinical Trials Day
May 20, 2015 | Tunis,Tunisia
International Clinical Trials Day is celebrated around the world on or near the 20 May each year, to commemorate the day that James Lind started his famous trial on the deadly disease scurvy in 1747.It provides a focal point to raise awareness of the importance of research to health care. Poseidon CRO , is happy and proud celebrating the 2015 International Clinical Trials Day ...
read more